Savillex Names New CEO

Eric Giesing offers broad expertise in life sciences.

Author Image

By: Charlie Sternberg

Associate Editor

Savillex has appointed Eric Giesing as Chief Executive Officer. An accomplished leader with broad expertise in life sciences, Giesing has previously held leadership positions at numerous life sciences companies. Most recently, he served as Chief Commercial Officer at Fortis Life Science.   “We are thrilled to welcome Eric Giesing as our new CEO,” said Matt Scherrer, Savillex board member and Managing Director at Thompson Street Capital Partners. “Eric’s commitment to fo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters